The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics
Abstract
In response to FDA's call for Quality by Design (QbD) in biopharmaceutical product development, the biopharmaceutical industry has been developing highly sensitive and specific technologies in the monitoring and controlling of product quality attributes for bioprocesses. We previously published the successful application of an off-line multi-attribute method (MAM) to monitor more than 20 critical quality attributes (CQA) with superior sensitivity for the upstream process. To further remove the hurdles of laborious process sampling and sample preparation associated with the offline method, we present here a fully integrated MAM based online platform for automated real time online process monitoring. This integrated system includes Modular Automated Sampling Technology (MAST) based aseptic sampling, multi-function Sequential Injection Analysis (SIA) sample preparation, UHPLC separation and high-resolution mass spectrometry (HRMS) analysis. Continuous automated daily monitoring of a 17-day cell culture process was successfully demonstrated for a model monoclonal antibody (mAb) molecule with similar specificity and sensitivity as we reported earlier. To the best of our knowledge, this is the first report of an end-to-end automated online MAM system, which would allow the MAM to be applied to routine bioprocess monitoring, potentially replacing multiple conventional low resolution and low sensitivity off-line methods. The online HPLC or HPLC/MS platform could be easily adapted to…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its utility for real‐time analysis in a PAT setting was recently explored where an end‐to‐end automated online MAM system was developed for quality attributes monitoring during upstream manufacturing [91].”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [91]
Citations
Cites
Esmonde-White, K. A., Cuellar, M., Uerpmann, C., Lenain, B., & Lewis, I. R. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9824-1 · Cited by 332
Rogers, R. S., Nightlinger, N. S., Livingston, B., Campbell, P., Bailey, R., & Balland, A. (2015) · mAbs · doi:10.1080/19420862.2015.1069454 · Cited by 231
Research works printed but not linked: 30
- Zitvogel, 2015, Cancer: antibodies regulate antitumor immunity, Nature, 7550, 35, 10.1038/nature14388 · DOI
- Chen, 2015, Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future, J Clin Investig, 125, 3384, 10.1172/JCI80011 · DOI · Paper page
- Redman, 2015, Mechanisms of action of therapeutic antibodies for cancer, Mol Immunol, 67, 28, 10.1016/j.molimm.2015.04.002 · DOI · Paper page
- Chen, 2013, Oncology meets immunology: the cancer immunity cycle, Immunity, 39, 1, 10.1016/j.immuni.2013.07.012 · DOI · Paper page
- Wang, 2016, Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion, MABs, 8, 1477, 10.1080/19420862.2016.1226715 · DOI
- Suurs, 2019, A review of bispecific antibodies and antibody constructs in oncology and clinical challenges, Pharmacol Thera, 201, 103, 10.1016/j.pharmthera.2019.04.006 · DOI · Paper page
- Rüttinger, 2018, BiTE antibodies: Directing T lymphocytes against tumor cells by bispecifity, J Onkol, 4
- Baldo, 2015, Chimeric fusion proteins used for therapy: indications, mechanisms, and safety, Drug Saf, 38, 455, 10.1007/s40264-015-0285-9 · DOI
- Fesnak, 2016, Engineered T cells: the promise and challenges of cancer immunotherapy, Nat Rev Cancer, 16, 566, 10.1038/nrc.2016.97 · DOI · Paper page
- Sheridan, 2015, First oncolytic virus edges towards approval in surprise vote, Nature Biotechnology, 33, 569, 10.1038/nbt0615-569 · DOI
- Carinhas, 2012, Systems biotechnology of animal cells: the road to prediction, Trends Biotechnol, 30, 377, 10.1016/j.tibtech.2012.03.004 · DOI
- Baik, 2014, Toward product attribute control: developments from genome sequencing, Curr Opin Biotechnol, 30, 40, 10.1016/j.copbio.2014.05.001 · DOI
- Streefland, 2013, Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production, Eng Life Sci, 13, 212, 10.1002/elsc.201200025 · DOI
- Patel, 2017, On-line ion exchange liquid chromatography as a process analytical technology for monoclonal antibody characterization in continuous bioprocessing, Anal. Chem, 89, 11357, 10.1021/acs.analchem.7b02228 · DOI
- Muteki, 2013, Quantitative structure retention relationship models in an analytical Quality by Design framework: simultaneously accounting for compound properties, mobile-phase conditions, and stationary-phase properties, Ind Eng Chem Res, 52, 12269, 10.1021/ie303459a · doi:10.1021/ie303459a
- Zalai, 2015, Advanced development strategies for biopharmaceutical cell culture processes, Curr Pharm Biotechnol, 16, 983, 10.2174/1389201016666150724100450 · doi:10.2174/1389201016666150724100450
- Teixeira, 2009, Advances in on-line monitoring and control of mammalian cell cultures: supporting the PAT initiative, Biotechnol Adv, 27, 726, 10.1016/j.biotechadv.2009.05.003 · DOI · Paper page
- Zhao, 2015, Advances in process monitoring tools for cell culture bioprocesses, Eng. Life Sci, 15, 459, 10.1002/elsc.201500006 · DOI · Paper page
- Buckley, 2017, Applications of Raman spectroscopy in biopharmaceutical manufacturing: a short review, Appl Spectrosc, 71, 1085, 10.1177/0003702817703270 · DOI · Paper page
- Chelius, 2008, Automated tryptic digestion procedure for HPLC/MS/MS peptide mapping of immunoglobulin gamma antibodies in pharmaceutics, J Pharm Biomed Anal, 47, 285, 10.1016/j.jpba.2008.01.018 · doi:10.1016/j.jpba.2008.01.018
- Ren, 2020, Advancing mass spectrometry technology in cGMP environments, Trends Biotechnol, 38, 1051, 10.1016/j.tibtech.2020.06.007 · DOI
- Lambertus, 2019, Development of universal, automated sample acquisition, preparation, and delivery devices and methods for pharmaceutical applications, Organic Process Res Dev, 23, 189, 10.1021/acs.oprd.8b00280 · DOI
- Richardson, 2011, Automated in-solution protein digestion using a commonly available high-performance liquid chromatography autosampler, Anal Biochem, 411, 284, 10.1016/j.ab.2011.01.019 · DOI
- Wu, 2015, Micro sequential injection system as the interfacing device for process analytical applications, Biotechnol Prog, 31, 607, 10.1002/btpr.2055 · DOI
- Ren, 2009, An improved trypsin digestion method minimizes digestion-induced modifications on proteins, Anal Biochem, 392, 12, 10.1016/j.ab.2009.05.018 · DOI · Paper page
- Liu, 2020, Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs, J Pharm Sci, 109, 3319, 10.1016/j.xphs.2020.07.029 · DOI
- Jakes, 2021, Tracking the behavior of monoclonal antibody product quality attributes using a multi-attribute method workflow, J Am Soc Mass Spectrom, 10.1021/jasms.0c00432 · DOI
- Dong, 2016, High-throughput, automated protein A purification platform with multi attribute LC−MS analysis for advanced cell culture process monitoring, Anal Chem, 88, 8673, 10.1021/acs.analchem.6b01956 · DOI
- Song, 2021, Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs, J Chromatogr B, 1166, 10.1016/j.jchromb.2021.122540 · DOI
- Xu, 2017, A quadrupole dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins, MAbs, 9, 1186, 10.1080/19420862.2017.1364326 · DOI
Cited by
Current PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45
Multi‐Dimensional Technology—Recent Advances and Applications for Biotherapeutic Characterization
Bouvarel, T., Camperi, J., & Guillarme, D. (2024) · Journal of Separation Science · doi:10.1002/jssc.202300928 · Cited by 20
Automated quality analysis in continuous downstream processes for small-scale applications
Tallvod, S., Espinoza, D., Gomis-Fons, J., Andersson, N., & Nilsson, B. (2023) · Journal of Chromatography A · doi:10.1016/j.chroma.2023.464085 · Cited by 11
Metadata
- Authors
- Liu, Y., Zhang, C., Chen, J., Fernandez, J., Vellala, P., Kulkarni, T. A., Aguilar, I., Ritz, D., Lan, K., Patel, P., & Liu, A.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 111
- Issue
- 2
- Pages
- 358-367
- ISSN
- 0022-3549
- Cited by
- 57
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics. https://app.cochat.ai/papers/10.1016/j.xphs.2021.09.011
- The paper
- Liu, Y., Zhang, C., Chen, J., Fernandez, J., Vellala, P., Kulkarni, T. A., Aguilar, I., Ritz, D., Lan, K., Patel, P., & Liu, A. (2022). A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2021.09.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.